Quick Answer
Sanofi reported Gross Profit of $33.67 billion for fiscal year 2025.
Sanofi Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $33.67B | +8.3% |
| 2024 | $31.08B | +7.2% |
| 2023 | $28.99B | +1.1% |
| 2022 | $28.68B | +6.5% |
| 2021 | $26.92B | +6.8% |
| 2020 | $25.21B | -1.7% |
| 2019 | $25.65B | +5.8% |
| 2018 | $24.24B | -1.5% |
| 2017 | $24.61B | +2.6% |
| 2016 | $24.00B | — |
- Sanofi showed an increase of +8.3% in Gross Profit compared to the prior fiscal year.
- Over the 2016–2025 period, Sanofi’s gross profit has grown by 40.3% (from $24.00 billion to $33.67 billion).
- The most recent figure is from Sanofi’s fiscal year 2025 report (Form 20-F), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: